Pedro Rosa‐Neto

33.3k total citations · 5 hit papers
422 papers, 13.7k citations indexed

About

Pedro Rosa‐Neto is a scholar working on Physiology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Pedro Rosa‐Neto has authored 422 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Physiology, 182 papers in Psychiatry and Mental health and 109 papers in Cognitive Neuroscience. Recurrent topics in Pedro Rosa‐Neto's work include Alzheimer's disease research and treatments (188 papers), Dementia and Cognitive Impairment Research (162 papers) and Functional Brain Connectivity Studies (82 papers). Pedro Rosa‐Neto is often cited by papers focused on Alzheimer's disease research and treatments (188 papers), Dementia and Cognitive Impairment Research (162 papers) and Functional Brain Connectivity Studies (82 papers). Pedro Rosa‐Neto collaborates with scholars based in Canada, United States and Brazil. Pedro Rosa‐Neto's co-authors include Serge Gauthier, Alan C. Evans, Tharick A. Pascoal, Yong He, Eduardo R. Zimmer, Andréa Lessa Benedet, Joseph Therriault, Arthur W. Toga, Susumu Mori and Roger P. Woods and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Pedro Rosa‐Neto

393 papers receiving 13.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template

2008 1.4k citations Pedro Rosa‐Neto et al. profile →
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

2021 390 citations Nicholas J. Ashton, Tharick A. Pascoal et al. profile →
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

2020 218 citations Thomas K. Karikari, Andréa Lessa Benedet et al. profile →
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

2022 170 citations Thomas K. Karikari, Nicholas J. Ashton et al. profile →
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

2023 101 citations Wagner S. Brum, Nicholas Cullen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro Rosa‐Neto Canada	56	4.5k	4.0k	4.0k	3.8k	2.1k	422	13.7k
Bart N.M. van Berckel Netherlands	57	3.9k 0.9×	4.3k 1.1×	2.4k 0.6×	2.7k 0.7×	1.4k 0.7×	274	10.7k
Stefan Teipel Germany	72	6.8k 1.5×	7.3k 1.8×	5.7k 1.4×	3.8k 1.0×	2.3k 1.1×	441	17.1k
Tammie L.S. Benzinger United States	61	7.5k 1.7×	6.0k 1.5×	4.1k 1.0×	3.3k 0.9×	3.2k 1.5×	397	16.4k
Deborah Blacker United States	57	5.8k 1.3×	7.3k 1.8×	9.0k 2.3×	4.5k 1.2×	2.5k 1.2×	188	22.1k
Adam M. Brickman United States	67	3.9k 0.9×	5.7k 1.4×	4.8k 1.2×	3.1k 0.8×	1.1k 0.5×	402	15.6k
David T. Jones United States	49	4.2k 0.9×	3.7k 0.9×	3.3k 0.8×	1.9k 0.5×	1.4k 0.7×	193	10.1k
Julie C. Price United States	69	7.2k 1.6×	7.2k 1.8×	5.2k 1.3×	3.5k 0.9×	2.0k 1.0×	259	17.6k
Kejal Kantarci United States	71	7.5k 1.7×	7.3k 1.8×	4.4k 1.1×	4.7k 1.2×	1.6k 0.8×	300	16.4k
Gene E. Alexander United States	62	5.0k 1.1×	4.5k 1.1×	3.9k 1.0×	2.2k 0.6×	1.7k 0.8×	175	11.7k
Alexander Drzezga Germany	71	4.9k 1.1×	5.0k 1.2×	5.0k 1.3×	5.6k 1.5×	1.5k 0.7×	382	15.8k

Countries citing papers authored by Pedro Rosa‐Neto

Since Specialization

Citations

This map shows the geographic impact of Pedro Rosa‐Neto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Rosa‐Neto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Rosa‐Neto more than expected).

Fields of papers citing papers by Pedro Rosa‐Neto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Rosa‐Neto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Rosa‐Neto. The network helps show where Pedro Rosa‐Neto may publish in the future.

Co-authorship network of co-authors of Pedro Rosa‐Neto

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Rosa‐Neto. A scholar is included among the top collaborators of Pedro Rosa‐Neto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Rosa‐Neto. Pedro Rosa‐Neto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brum, Wagner S., Nicholas Cullen, Joseph Therriault, et al.. (2024). A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings. Nature Communications. 15(1). 2311–2311. 15 indexed citations

Kunach, Peter, Jaime Vaquer‐Alicea, Robert Hopewell, et al.. (2024). Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240. Nature Communications. 15(1). 8497–8497. 19 indexed citations

Lussier, Firoza Z, Guilherme Povala, Debra Fine, et al.. (2024). Longitudinal multicenter head‐to‐head harmonization of tau‐PET tracers: an overview of the HEAD study cohort. Alzheimer s & Dementia. 20(S9). 1 indexed citations

Therriault, Joseph, Antonio Aliaga, Arthur C. Macedo, et al.. (2024). Plasma p‐tau217 outperforms [¹⁸F]FDG‐PET in identifying biological Alzheimer’s disease in atypical and early‐onset dementia. Alzheimer s & Dementia. 20(S2). 1 indexed citations

Povala, Guilherme, Bruna Bellaver, Firoza Z Lussier, et al.. (2024). Universal tau PET scale (Uniτ) – The HEAD Study. Alzheimer s & Dementia. 20(S2). 1 indexed citations

Hosseini, Seyyed Ali, Isaac Shiri, Ghasem Hajianfar, et al.. (2024). The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods. Annals of Nuclear Medicine. 38(7). 493–507. 10 indexed citations

Moquin, Luc, Min Su Kang, Atsuko Nagano‐Saito, et al.. (2024). Testing PET-[11C]ABP688 as a tool to quantify glutamate release in vivo. Imaging Neuroscience. 2. 1 indexed citations

Tardif, Christine, Ilana R. Leppert, Claudine Gauthier, et al.. (2024). Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status. Nature Communications. 15(1). 4706–4706. 9 indexed citations

Ottoy, Julie, Min Su Kang, Reinder Vos de Wael, et al.. (2023). Mapping the effects of functional and structural network reorganization on the tau‐cognition relationship in Alzheimer’s disease. Alzheimer s & Dementia. 19(S14).

10.

Bezgin, Gleb, Tharick A. Pascoal, Jenna Stevenson, et al.. (2023). Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum. Frontiers in Aging Neuroscience. 15. 1225816–1225816. 1 indexed citations

11.

Hosseini, Seyyed Ali, Stijn Servaes, Joseph Therriault, et al.. (2023). Quantitative evaluation of oxygen extraction fraction (OEF) in Alzheimer's disease: A correlation with tau and amyloid pathology and cognitive status. Journal of the Neurological Sciences. 455. 121101–121101.

12.

Benedet, Andréa Lessa, Gallen Triana‐Baltzer, Guglielmo Di Molfetta, et al.. (2023). Plasma pTau217: single vs multiple phospho‐site assays.. Alzheimer s & Dementia. 19(S24). 2 indexed citations

13.

Hosseini, Seyyed Ali, Stijn Servaes, Joseph Therriault, et al.. (2023). Assessment of quantitative susceptibility mapping (QSM) and oxygen extraction fraction (OEF) in the spectrum of Alzheimer’s disease clinical presentations. Alzheimer s & Dementia. 19(S17).

14.

Ng, Kok Pin, Pedro Rosa‐Neto, Serge Gauthier, et al.. (2023). Visual Cognitive Assessment Test (VCAT): Utility in detecting early dementia in diverse language cohorts. Alzheimer s & Dementia. 19(S18).

15.

Iturria‐Medina, Yasser, Simon Ducharme, Pedro Rosa‐Neto, et al.. (2022). Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Science Advances. 8(46). eabo6764–eabo6764. 43 indexed citations

16.

Pascoal, Tharick A., Joseph Therriault, Min Su Kang, et al.. (2021). Interactive rather than independent effect of APOE and sex potentiates tau deposition in women. Brain Communications. 3(2). fcab126–fcab126. 18 indexed citations

17.

Jiang, Lai, Karim Oualkacha, Vanessa Didelez, et al.. (2019). Constrained instruments and their application to Mendelian randomization with pleiotropy. Genetic Epidemiology. 43(4). 373–401. 11 indexed citations

18.

Li, Xiaofeng, Maowen Ba, Kok Pin Ng, et al.. (2017). Characterizing biomarker features of cognitively normal individuals with ventriculomegaly. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 10(1). 12–21. 10 indexed citations

19.

Turgeon, Maxime, Karim Oualkacha, Antonio Ciampi, et al.. (2016). Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies. Statistical Methods in Medical Research. 27(5). 1331–1350. 8 indexed citations

20.

Parent, Maxime, Marc‐André Bédard, Luciano Minuzzi, et al.. (2013). Cholinergic Depletion in Alzheimer’s Disease Shown by [¹⁸F]FEOBV Autoradiography. PubMed. 2013. 1–6. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact